 After diagnose Yuxtafoveal telangiectasias secondary to Branch Retinal Vein Occlusion and with Idiopathic Ethiology by clinical signs and Fluorescein angiogram FAfindings we treated patients with Intravitreal Injection of Bevacizumab 2.5mg0.1ml. We performed a complete ophthalmological evaluation and at baseline and follow-up 1 and 3 months we evaluate ETDRS Best Corrected visual acuity BCVA, fluorescein angiogram FA and Optical Coherence Tomography OCTfindings. We found an improvement in visual acuity and reduction of FA leakage and decrease retinal thickness in OCT. 